Контраст-індукована нефропатія (огляд літератури і власні дані)

M. T. Vatutin, M. I. Zinkovych

Анотація


У даному огляді представлені відомості про частоту розвитку контраст-індукованої нефропатії у пацієнтів з ішемічною хворобою серця, які піддавалися черезшкірному коронарному втручанню з внутрішньосудинним уведенням рентгеноконтрастних препаратів. Наведено дані про патогенез, стратифікацію факторів ризику та клінічні прояви контраст-індукованої нефропатії. Також відображені результати виконаних на даний момент досліджень, про можливі лікувальні заходи, які спрямовані на профілактику виникнення даної нефропатії.


Ключові слова


ураження нирок; контраст-індукована нефропатія; контрастний препарат; ішемічна хвороба серця

Повний текст:

PDF

Посилання


Vatutin NT. Neotlozhnaya kardiologiya [Emergency cardiology]. Donetsk: FO-P; 2011. 236 p. (in Russian).

Volgina GV. Kontrast indutsirovannaya nefropatiya: patogenez, faktory riska, strategiya profilaktiki [Contrast induced nephropathy: pathogenesis, risk factors, prevention strategy]. Nefrologiya i dializ. 2006;8(2):176-82. (in Russian).

Coyle LC, Rodriguez A, Jeschke RE. Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics. Am. Heart J. 2006;151(5):1032.e 9-12.

Budhiraja P, Chen Z, Popovtzer M. Sodium bicarbonate versus normal saline for protection against contrast nephropathy. Ren Fail. 2009;31(2):118-23.

bu Jawdeh BG, Kanso AA, Schelling JR. Evidence-based approach for prevention of radiocontrast-induced nephropathy. J. Hosp. Med. 2009;4(8):500-06.

Chong E, Poh KK, Liang S. Comparison of risks and clinical predictors of contrastinduced nephropathy in patients undergoing emergency versus nonemergency percutaneous coronary interventions. J. Interv. Cardiol. 2010;23(5):451-59.

Caruso M, Balasus F, Incalcaterra E. Contrast-induced nephropathy after percutaneous coronary intervention in simple lesions: risk factors and incidence are affected by the definition utilized. Intern. Med. 2011;50(9):983-89.

Detrenis S, Meschi M, Bertolini L. Contrast medium administration in the elderly patient: is advancing age an independent risk factor for contrast nephropathy after angiographic procedures? J. Vasc. Interv. Radiol. 2007;18(2):177-85.

Cowburn PJ, Patel H, Pipes RR. Contrast nephropathy post cardiac resynchronization therapy: an under-recognized complication with important morbidity. Eur. J. Heart Fail. 2005;7(5):899-903.

Kedrah AE, Ari E, Alahdab Y. Effect of the direct renin inhibitor aliskiren in the prevention of experimental contrast-induced nephropathy in the rat. Kidney Blood Press Res. 2012;35(6):425-30.

Albabtain MA, Almasood A, Alshurafah H. Efficacy of Ascorbic Acid, N-Acetylcysteine, or Combination of Both on Top of Saline Hydration versus Saline Hydration Alone on Prevention of Contrast-Induced Nephropathy: A Prospective Randomized Study J. Interv. Cardiol. 2013;26(1):90-6.

Gami AS, Garovic VD. Contrast nephropathy after coronary angiography. Mayo Clin. Proc. 2004;79(2):211-19.

Goldenberg I, Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ. 2005;172(11):1461-71.

Gomes VO, Lasevitch R, Lima VC. Hydration with sodium bicarbonate does not prevent contrast nephropathy: a multicenter clinical trial. Arq Bras. Cardiol. 2012;99(6):1129-134.

Conen D, Buerkle G, Perruchoud AP. Hypertension is an independent risk factor for contrast nephropathy after percutaneous coronary intervention. Int. J. Cardiol. 2006;110(2):237-41.

Quintavalle C, Fiore D, De MF. Impact of a high loading dose of atorvastatin on contrastinduced acute kidney injury. Circulation. 2012;126(25):3008-16.

Jorgensen AL. Contrast-induced nephropathy: pathophysiology and preventive strategies. Crit Care Nurse. 2013;33(1):37-46.

Kunadian V, Zaman A, Spyridopoulos, I, Qiu W. Sodium bicarbonate for the prevention of contrast induced nephropathy: a meta-analysis of published clinical trials. Eur. J. Radiol. 2011;79(1):48-55.

Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int. Suppl. 2006;100:S11-S15.

Morcos SK, Thomsen HS, Webb JA. Contrast-media-induced nephrotoxicity: a consensus report. Eur.Radiol. 1999; 9(8):1602-13.

Murphy SW, Barrett BJ, Parfrey PS. Contrast nephropathy. J. Am. Soc. Nephrol. 2000;11(1):177-82.

Jaipaul N, Manalo R, Sadjadi SA. Obesity is not associated with contrast nephropathy. J. Ther. Clin. Risk Manag. 2010;6:213-17.

Markota D, Markota I, Starcevic B. Prevention of contrast-induced nephropathy with Na / K Citrate. Eur. Heart J. 2013;34:2362-67.

Merten GJ, Burgess WP, Gray LV. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004;291:2328-34.

Gulel O, Keles T, Eraslan H. Prophylactic acetylcysteine usage for prevention of contrast nephropathy after coronary angiography. J. Cardiovasc. Pharmacol. 2005;46(4):464-67.

Drager LF, Andrade L, Barros de Toledo JF. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury. Nephrol. Dial. Transplant. 2004;19(7):1803-07.

Krusova D, Sevela K, Kralova D. Risky medication and contrast media-induced nephropathy in patients with diabetes and hypertension. Vnitr. Lek. 2006;52(11):1014-20.

Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation. 2006;113(14):1799-1806.

Teplan V. Contrast nephropathy and prevention. Vnitr. Lek. 2012;58(7-8): 553-56.

Oguzhan N, Cilan H, Sipahioglu M. The Lack of Benefit of a Combination of an Angiotensin Receptor Blocker and Calcium Channel Blocker on Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease. Ren Fail. 2013;35(4):434-39.

Gare M, Haviv YS, Ben-Yehuda A. The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography. J. Am. Coll. Cardiol. 1999;34(6):1682-88.

Bachorzewska-Gajewska H, Malyszko J, Malyszko JS. Undiagnosed renal impairment in patients with and without diabetes with normal serum creatinine undergoing percutaneous coronary intervention. Nephrology. (Carlton). 2006;11(6):549-54.


Пристатейна бібліографія ГОСТ






DOI: https://doi.org/10.24061/106034

Посилання

  • Поки немає зовнішніх посилань.


Copyright (c) 2017 M. T. Vatutin, M. I. Zinkovych

Технічний редактор журналу, к.мед.н. М. Степанченко, 2015-2017